A carregar...
Kynurenine Pathway Metabolites as Biomarkers for Amyotrophic Lateral Sclerosis
Amyotrophic Lateral Sclerosis (ALS) currently lacks a robust and well-defined biomarker that can 1) assess the progression of the disease, 2) predict and/or delineate the various clinical subtypes, and 3) evaluate or predict a patient’s response to treatments. The kynurenine Pathway (KP) of tryptoph...
Na minha lista:
| Publicado no: | Front Neurosci |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6764462/ https://ncbi.nlm.nih.gov/pubmed/31616242 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fnins.2019.01013 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|